diffuse large cell lymphoma

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)

Terminated
  • Mantle Cell Lymphoma
  • +4 more
  • cellular immunotherapy
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)

Completed
  • Diffuse Large Cell Lymphoma
  • +2 more
  • Buffalo, New York
  • +4 more
Oct 29, 2021

Acute Lymphocytic Leukemia, Diffuse Large Cell Lymphoma Trial in Philadelphia (huCART19)

Completed
  • Acute Lymphocytic Leukemia
  • Diffuse Large Cell Lymphoma
  • huCART19
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Sep 22, 2021

Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)

Completed
  • Diffuse Large Cell Lymphoma
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Cincinnati (CPX-351)

Completed
  • Acute Myeloid Leukemia
  • +7 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 6, 2020

Diffuse Large Cell Lymphoma Trial in Belgium, France, Switzerland (rituximab)

Terminated
  • Diffuse Large Cell Lymphoma
  • Mont-Godinne, Belgium
  • +10 more
Mar 9, 2017

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (anti-CD19 CAR-NK cells)

Unknown status
  • Acute Lymphocytic Leukemia
  • +5 more
  • anti-CD19 CAR-NK cells
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Dec 4, 2016

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (PCAR-019 (anti-CD19 CAR-T cells))

Unknown status
  • Acute Lymphocytic Leukemia
  • +5 more
  • PCAR-019 (anti-CD19 CAR-T cells)
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Oct 23, 2016

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (PCAR-019 (anti-CD19 CAR-T cells))

Unknown status
  • Acute Lymphocytic Leukemia
  • +5 more
  • PCAR-019 (anti-CD19 CAR-T cells)
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Jul 28, 2016

Non-Hodgkin's Lymphoma, Follicular Lymphoma, Diffuse Large Cell Lymphoma Trial in La Jolla (ISF35)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • ISF35
  • La Jolla, California
    University of California, San Diego Moores Cancer Center
Nov 30, 2015

Diffuse Large Cell Lymphoma Trial in Belgium, France, Switzerland (rituximab, doxorubicin, cyclophosphamide)

Completed
  • Diffuse Large Cell Lymphoma
  • Mont-Godinne, Belgium
  • +12 more
Sep 1, 2015

Diffuse Large Cell Lymphoma Trial in Belgium, France, Switzerland (Darbepoetin alfa)

Completed
  • Diffuse Large Cell Lymphoma
  • Darbepoetin alfa
  • Gent, Belgium
  • +13 more
Sep 1, 2015

Diffuse Large Cell Lymphoma Trial in France (Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX))

Completed
  • Diffuse Large Cell Lymphoma
  • Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX)
  • Créteil, France
  • +7 more
Sep 1, 2015

Non-Hodgkin's Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in Stanford (Rituximab 375 mg/m2)

Completed
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Rituximab 375 mg/m2
  • Stanford, California
    Stanford University Medical Center
Sep 4, 2014

Hodgkin's Lymphoma, Low Grade Lymphoma, Lymphoma Trial (AMG 655, Vorinostat, Bortezomib)

Completed
  • Hodgkin's Lymphoma
  • +5 more
  • AMG 655
  • +2 more
  • (no location specified)
Mar 3, 2014

Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

Completed
  • Follicular Lymphoma
  • +4 more
  • Birmingham, Alabama
  • +10 more
Jun 24, 2011

Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Italy (Treosulfan IV)

Unknown status
  • Leukemia
  • +6 more
  • Treosulfan IV
  • San Giovanni Rotondo, Foggia, Italy
  • +11 more
Aug 10, 2009